Goodrx Holdings Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.5% | 8.1% | 21.5% | 4.8% | 44.5% | 22.5% | 4.6% | 24.4% | 38.8% | 16.9% | 6.1% | 40.3% | 25.7% | |
| 18.4% | 22.2% | 8.1% | 8.5% | 9.0% | 9.6% | 10.3% | 9.7% | 10.9% | 11.9% | 11.2% | 11.1% | 11.3% | |
| 18.1% | 14.6% | 12.7% | 13.3% | 13.5% | 10.6% | 9.4% | 10.5% | 9.2% | 9.2% | 8.5% | 8.3% | 8.8% | |
| 9.2% | -14.1% | 0.4% | -21.1% | 18.5% | 3.8% | -23.6% | -3.0% | 13.2% | -14.5% | -17.5% | 12.0% | -1.6% | |
| 7.6% | 6.5% | 10.4% | 8.6% | 0.2% | 8.4% | 10.8% | 9.0% | 9.2% | 8.1% | 11.2% | 0.2% | 7.1% | |
| -7.6% | -6.5% | -10.4% | -8.6% | -8.1% | -8.4% | -25.6% | -9.0% | -9.2% | -16.3% | -11.2% | -7.2% | -10.9% | |
| 1.7% | 2.2% | – | – | – | – | – | – | – | – | – | – | – | |
| -4.3% | -39.6% | -77.4% | -4.6% | -2.8% | -0.1% | -49.2% | -22.6% | -31.1% | -4.8% | -6.5% | -1.0% | -10.8% | |
| – | – | – | – | -82.8% | 0.0% | -0.6% | -0.6% | -0.6% | -0.6% | -0.6% | -0.6% | -0.6% | |
| -7.6% | -63.9% | -81.3% | -0.4% | -88.2% | -1.8% | -51.7% | -25.1% | -33.6% | -6.6% | -8.4% | -3.0% | -12.9% | |
| 18.3% | -62.4% | -70.2% | -4.2% | -51.8% | 12.4% | -72.6% | -9.7% | -4.0% | -6.0% | -13.5% | 30.1% | 1.9% | |
| 25.9% | 1.5% | 11.1% | -3.8% | 44.3% | 14.1% | -6.1% | 15.4% | 29.6% | 8.8% | -5.1% | 40.2% | 18.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.